Efficacy and safety of sunitinib in patients with metastatic renal cell carcinoma on hemodialysis.


4646 Background: Sunitinib treatment is currently a standard of care for the treatment of metastatic renal cell carcinoma. Patients (pts) on hemodialysis however were excluded from studies and only few cases of pts on hemodialysis have been reported. METHODS We have performed a retrospective study by contacting over 100 hemodialysis institutions in… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics